Ankylosing Spondylitis

A Contemporary Perspective on Diagnosis and Treatment

Mark Mansour, Gurtej S. Cheema, Stanley M Naguwa, Adam Greenspan, Andrea T. Borchers, Carl L Keen, M. Eric Gershwin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objectives: In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the understanding of the pathogenesis of ankylosing spondylitis (AS). The purpose of this review was to summarize these developments. Methods: We performed a PubMed search for the period 1978 to 2005, using the keyword, "ankylosing spondylitis," resulting in a total of 4878 publications, including 778 reviews. Articles were then selected based on their discussion of recent diagnostic tools and new treatment approaches in the pathogenesis of AS, leading to a final total of 104 articles. Results: In recent years, there have been 2 major developments in the management of AS that make earlier diagnosis possible and offer the hope of alleviating pain and preventing structural changes that result in loss of function. These developments include the use of magnetic resonance imaging to visualize the inflammatory changes in the sacroiliac joint and the axial spine, and the demonstration that tumor necrosis factor blocking agents are highly efficacious in reducing spinal inflammation and possibly in slowing radiographic progression. Conclusions: There have been major advances in both the diagnostic tools and the therapeutic regimens available for patients with AS.

Original languageEnglish (US)
Pages (from-to)210-223
Number of pages14
JournalSeminars in Arthritis and Rheumatism
Volume36
Issue number4
DOIs
StatePublished - Feb 2007

Fingerprint

Ankylosing Spondylitis
Therapeutics
Sacroiliac Joint
PubMed
Publications
Early Diagnosis
Spine
Tumor Necrosis Factor-alpha
Magnetic Resonance Imaging
Outcome Assessment (Health Care)
Inflammation
Pain

Keywords

  • computed tomography
  • sacroiliitis, HLA B27
  • seronegative spondyloarthritis
  • TNF blocking agents

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Ankylosing Spondylitis : A Contemporary Perspective on Diagnosis and Treatment. / Mansour, Mark; Cheema, Gurtej S.; Naguwa, Stanley M; Greenspan, Adam; Borchers, Andrea T.; Keen, Carl L; Gershwin, M. Eric.

In: Seminars in Arthritis and Rheumatism, Vol. 36, No. 4, 02.2007, p. 210-223.

Research output: Contribution to journalArticle

@article{0ab70eb8bad94e0daa0d6e55f3130bda,
title = "Ankylosing Spondylitis: A Contemporary Perspective on Diagnosis and Treatment",
abstract = "Objectives: In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the understanding of the pathogenesis of ankylosing spondylitis (AS). The purpose of this review was to summarize these developments. Methods: We performed a PubMed search for the period 1978 to 2005, using the keyword, {"}ankylosing spondylitis,{"} resulting in a total of 4878 publications, including 778 reviews. Articles were then selected based on their discussion of recent diagnostic tools and new treatment approaches in the pathogenesis of AS, leading to a final total of 104 articles. Results: In recent years, there have been 2 major developments in the management of AS that make earlier diagnosis possible and offer the hope of alleviating pain and preventing structural changes that result in loss of function. These developments include the use of magnetic resonance imaging to visualize the inflammatory changes in the sacroiliac joint and the axial spine, and the demonstration that tumor necrosis factor blocking agents are highly efficacious in reducing spinal inflammation and possibly in slowing radiographic progression. Conclusions: There have been major advances in both the diagnostic tools and the therapeutic regimens available for patients with AS.",
keywords = "computed tomography, sacroiliitis, HLA B27, seronegative spondyloarthritis, TNF blocking agents",
author = "Mark Mansour and Cheema, {Gurtej S.} and Naguwa, {Stanley M} and Adam Greenspan and Borchers, {Andrea T.} and Keen, {Carl L} and Gershwin, {M. Eric}",
year = "2007",
month = "2",
doi = "10.1016/j.semarthrit.2006.08.003",
language = "English (US)",
volume = "36",
pages = "210--223",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Ankylosing Spondylitis

T2 - A Contemporary Perspective on Diagnosis and Treatment

AU - Mansour, Mark

AU - Cheema, Gurtej S.

AU - Naguwa, Stanley M

AU - Greenspan, Adam

AU - Borchers, Andrea T.

AU - Keen, Carl L

AU - Gershwin, M. Eric

PY - 2007/2

Y1 - 2007/2

N2 - Objectives: In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the understanding of the pathogenesis of ankylosing spondylitis (AS). The purpose of this review was to summarize these developments. Methods: We performed a PubMed search for the period 1978 to 2005, using the keyword, "ankylosing spondylitis," resulting in a total of 4878 publications, including 778 reviews. Articles were then selected based on their discussion of recent diagnostic tools and new treatment approaches in the pathogenesis of AS, leading to a final total of 104 articles. Results: In recent years, there have been 2 major developments in the management of AS that make earlier diagnosis possible and offer the hope of alleviating pain and preventing structural changes that result in loss of function. These developments include the use of magnetic resonance imaging to visualize the inflammatory changes in the sacroiliac joint and the axial spine, and the demonstration that tumor necrosis factor blocking agents are highly efficacious in reducing spinal inflammation and possibly in slowing radiographic progression. Conclusions: There have been major advances in both the diagnostic tools and the therapeutic regimens available for patients with AS.

AB - Objectives: In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the understanding of the pathogenesis of ankylosing spondylitis (AS). The purpose of this review was to summarize these developments. Methods: We performed a PubMed search for the period 1978 to 2005, using the keyword, "ankylosing spondylitis," resulting in a total of 4878 publications, including 778 reviews. Articles were then selected based on their discussion of recent diagnostic tools and new treatment approaches in the pathogenesis of AS, leading to a final total of 104 articles. Results: In recent years, there have been 2 major developments in the management of AS that make earlier diagnosis possible and offer the hope of alleviating pain and preventing structural changes that result in loss of function. These developments include the use of magnetic resonance imaging to visualize the inflammatory changes in the sacroiliac joint and the axial spine, and the demonstration that tumor necrosis factor blocking agents are highly efficacious in reducing spinal inflammation and possibly in slowing radiographic progression. Conclusions: There have been major advances in both the diagnostic tools and the therapeutic regimens available for patients with AS.

KW - computed tomography

KW - sacroiliitis, HLA B27

KW - seronegative spondyloarthritis

KW - TNF blocking agents

UR - http://www.scopus.com/inward/record.url?scp=33846647017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846647017&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2006.08.003

DO - 10.1016/j.semarthrit.2006.08.003

M3 - Article

VL - 36

SP - 210

EP - 223

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 4

ER -